Tuesday, August 4, 2026

Are Korean Universities Ready for the Surge in Medical Students?

Seoul's medical schools face faculty shortages and infrastructure issues amid expanded enrollment, raising concerns about education quality.

Kim Jong Un Inspects New Destroyer with Daughter and Orders Delivery to Navy by Mid-June

Kim Jong Un inspects North Korea's new destroyer, Choe Hyon, ensuring its readiness for navy delivery by mid-June, emphasizing military upgrades.

Actor Jung Woo Sung: “Marriage Isn’t Possible,” Yet Fatherhood Surprises Fans

Actor Jung Woo Sung reveals he is the father of a son with model Moon Gabi, sparking debate over his past comments on relationships.

Tag: FDA

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

ABL Bio to Launch Global Phase 3 Trial of Gastric Cancer Drug Givastomig This Year at BIO USA

ABL Bio plans a Phase 3 trial for gastric cancer therapy Givastomig, targeting a $2.5 billion market opportunity.

New Hope for IPF Patients: How Jascayd is Revolutionizing Treatment in 2026

Jascayd offers new hope for idiopathic pulmonary fibrosis patients, slowing lung function decline with a novel mechanism of action.

JPi Healthcare’s DRE Duo: FDA Approval Opens Doors to the U.S. Market

JPi Healthcare launches its DRE Duo digital X-ray system in the U.S., enhancing global expansion and targeting international markets.

SK Biopharm’s Xcopri: How This CNS Drug is Redefining Global Market Strategies

SK Biopharm aims to enhance its CNS leadership and foster Asian biotech connections with global markets through open innovation and collaboration.

How Angeliq and Other Treatments Are Transforming Menopausal Care in 2026

Daewon Pharmaceutical's symposium focused on menopausal hormone therapy, featuring discussions on Angeliq and recent clinical findings.

21 Companies Caught Misleading Consumers with False Health Claims on Haskap Berry Products

FDA warns against misleading ads for foods marketed as health supplements, leading to investigations of 21 companies for false claims.

U.S. FDA to Streamline IND Process: What It Means for Asian Biotech Competitiveness in 2027

The U.S. aims to streamline drug approval processes to compete with China and Australia in attracting clinical trials, enhancing biotech growth.

Seers Moves Closer to U.S. Launch of Wearable AI ECG Device After Completing Final FDA Filing

Wearable AI diagnostic firm Searis has completed the final document submission for FDA 510(k) approval of its mobiCARE™ ECG solution.

U.S., Japan and China Advance Stem Cell Commercialization While Korea Works to Close Gaps

The global stem cell therapy market is rapidly growing, but South Korea faces challenges in commercialization compared to the U.S. and Japan.

Wontech Expands Surgical Device Business With $2.2 Million HOLINWON Supply Deals in Uzbekistan and Indonesia

Wontech expands into surgical devices, securing $2.2M contracts in Asia for its advanced holmium laser technology.

HLB Group Maps Commercialization Push as It Awaits Key U.S. Cancer Drug Decisions

HLB Group seeks FDA approval for cancer drugs, aiming for global impact through innovation and collaboration in the biotech sector.

Artiva to Advance NK Cell Therapy Into Phase 3 for Rheumatoid Arthritis After Positive Mid-Stage Data

GC Cell's Artiva Biotherapeutics advances NK cell therapy AlloNK to Phase 3 trials for rheumatoid arthritis after promising Phase 2 results.

FDA Approval Allows AlphaTau to Broaden IMPACT Trial in Pancreatic Cancer

AlphaTau Medical expands its pancreatic cancer trial with FDA approval, adding 10 patients for a combination treatment approach.

L&K BioMed Showcases Innovative Products at the AANS Conference in Texas

L&K BioMed showcased its products at the AANS conference, receiving positive feedback and interest for its cervical products, aiming to expand in the U.S. market.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.